Clinical trial
Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in…
NCT00085059 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated
Key facts
| NCT number | NCT00085059 |
|---|---|
| Title | Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma |
| Official title | Early Phase II Study On BNCT In Metastatic Malignant Melanoma Using The Boron Carrier BPA |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | boronophenylalanine-fructose complex |
| Enrollment | 4 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2006 |
| First posted | Jun 11, 2004 |
| Last update posted | Jul 18, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: